Variant report
Variant | nsv1025990 |
---|---|
Chromosome Location | chr6:65604405-65649707 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs563629739 | chr6:65612226-65612227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs532560319 | chr6:65612265-65612266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs552381873 | chr6:65612271-65612272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs559249431 | chr6:65612289-65612290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs75634595 | chr6:65612302-65612303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528657355 | chr6:65612444-65612445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548797634 | chr6:65612452-65612453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs568576730 | chr6:65612473-65612474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs531080261 | chr6:65612483-65612484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs79920226 | chr6:65612529-65612530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569266391 | chr6:65612530-65612531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs184640433 | chr6:65612559-65612560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs544810443 | chr6:65612561-65612562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs150556678 | chr6:65612562-65612563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs72873051 | chr6:65612667-65612668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs534438255 | chr6:65612671-65612672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs554724154 | chr6:65612710-65612711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs78205005 | chr6:65612769-65612770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs543701786 | chr6:65612882-65612883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs376643020 | chr6:65612895-65612896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs557334840 | chr6:65612898-65612899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs190494220 | chr6:65612946-65612947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546208230 | chr6:65612957-65612958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs373599537 | chr6:65612960-65612961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs559577501 | chr6:65612992-65612993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs528551277 | chr6:65613007-65613008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530602098 | chr6:65613047-65613048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541031287 | chr6:65613076-65613077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs541979264 | chr6:65613134-65613135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs561899426 | chr6:65613164-65613165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs531016880 | chr6:65613184-65613185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs116487765 | chr6:65613187-65613188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570854216 | chr6:65613213-65613214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs73767160 | chr6:65613401-65613402 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs16895989 | chr6:65613486-65613487 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs565564926 | chr6:65613490-65613491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs534668543 | chr6:65613527-65613528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs546323809 | chr6:65614019-65614020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs564421517 | chr6:65614021-65614022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565327893 | chr6:65614060-65614061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs9354190 | chr6:65614089-65614090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs559262498 | chr6:65614093-65614094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528116731 | chr6:65614107-65614108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs548304099 | chr6:65614112-65614113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568190357 | chr6:65614119-65614120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs201216249 | chr6:65614165-65614166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs144481540 | chr6:65614173-65614174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs550760364 | chr6:65614175-65614176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs570681979 | chr6:65614210-65614211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs539670846 | chr6:65614216-65614217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Epilepsy | 20502679 | CNVD |
Dyslexia | 22102821 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:65612200-65613400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
2 | chr6:65612600-65613400 | Enhancers | Fetal Brain Female | brain |
3 | chr6:65613200-65613600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
4 | chr6:65614000-65614600 | Enhancers | HUVEC | blood vessel |
5 | chr6:65614200-65615400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
6 | chr6:65614600-65615000 | Flanking Active TSS | HUVEC | blood vessel |
7 | chr6:65615000-65615600 | Enhancers | HUVEC | blood vessel |
8 | chr6:65621200-65622000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
9 | chr6:65623600-65624400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
10 | chr6:65623800-65624200 | Enhancers | Hela-S3 | cervix |
11 | chr6:65626000-65626800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr6:65626200-65626600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr6:65631800-65632200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
14 | chr6:65635600-65636200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
15 | chr6:65640600-65641000 | Enhancers | Fetal Brain Female | brain |
16 | chr6:65640800-65642200 | Weak transcription | Esophagus | oesophagus |
17 | chr6:65642200-65642600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |